Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$14.57
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Entrada Therapeutics (TRDA) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Promising
Entrada Therapeutics (NASDAQ:TRDA) Stock Quotes, Forecast and News Summary
Entrada Therapeutics Stock (NASDAQ: TRDA) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 144.41K |
| Day Range | - - - |
| 52 Wk Range | 10.75 - 18.17 |
| Market Cap | $542.00M |
| P/E Ratio | 4.82 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 44 |
| Short Interest | 9.25% |
| Days to Cover | 13.06 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Entrada Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of p...
Show More
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Entrada Therapeutics (TRDA) stock?
You can purchase shares of Entrada Therapeutics (NASDAQ:TRDA) through any online brokerage.
Who are Entrada Therapeutics (TRDA) competitors?
Other companies in Entrada Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), Valneva (NASDAQ:VALN), 4D Molecular Therapeutics (NASDAQ:FDMT), Celcuity (NASDAQ:CELC) and Altimmune (NASDAQ:ALT).
What is the forecast, or price target, for Entrada Therapeutics (TRDA) stock?
Entrada Therapeutics has a consensus price target of $20.75.
What is the current price for Entrada Therapeutics (TRDA)?
The stock price for Entrada Therapeutics (NASDAQ: TRDA) is $14.57 last updated September 23, 2024 at 4:00 PM EDT.
Does Entrada Therapeutics (TRDA) pay a dividend?
There are no upcoming dividends for Entrada Therapeutics.
When is Entrada Therapeutics (NASDAQ:TRDA) reporting earnings?
Entrada Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
Is Entrada Therapeutics (TRDA) going to split?
There is no upcoming split for Entrada Therapeutics.
What sector and industry does Entrada Therapeutics (TRDA) operate in?
Entrada Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.